Form 4: Arcus Biosciences Executive Sells Shares
Insider Transaction (Form 4)
Alexander Azoy, Chief Accounting Officer of Arcus Biosciences, Inc., sold 2,827 shares of common stock on August 21, 2026 for $30.00 per share.
Summary
- Option exercise/conversion: acquired 2,827 Common Stock at $15.44 ($43,649) on August 21, 2026; holds 42,408 after (Direct).
- Open-market sale: disposed of 2,827 Common Stock at $30.00 ($84,810) on August 21, 2026; holds 39,581 after (Direct).
- Option exercise/conversion: disposed of 2,827 Stock Option (right to buy) on August 21, 2026; holds 3,073 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $84,810 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Alexander Azoy — Officer (Chief Accounting Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Option exercise/conversion | Common Stock | 2,827 | $15 | $43.6K | 42,408 |
| 2026-08-21 | Open-market sale | Common Stock | 2,827 | $30 | $84.8K | 39,581 |
| 2026-08-21 | Option exercise/conversion | Stock Option (right to buy) | 2,827 | — | — | 3,073 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Option exercise/conversion (2,827 shares) |
| 2026-08-21 | Open-market sale (2,827 shares) |
| 2026-08-21 | Option exercise/conversion (2,827 shares) |
Keywords
insider transaction, Form 4, RCUS, Arcus Biosciences, Inc., bearish, Alexander Azoy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.